You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
19 January 2026 - Precision oncology company Guardant Health Inc (Nasdaq: GH) announced on Monday that it has entered into a multi-year strategic collaboration with pharmaceutical firm Merck, known as MSD outside the United States and Canada, to supp...
19 January 2026 - Biopharmaceutical company Akeso Inc (HKEX: 9926.HK) announced on Monday that the National Medical Products Administration Center for Drug Evaluation has accepted its supplemental New Drug Application for gumokimab (AK111), a humanis...
19 January 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Monday that the European Medicines Agency has validated a Type II Variation marketing authorisation application for ENHERTU (trastuzumab deruxtecan) in combin...
19 January 2026 - Pancreatic cancer diagnostics company Immunovia AB (STO:IMMNOV) announced on Monday that it has received regulatory approval to offer its PancreaSure test commercially in California, marking a key milestone in its three-phase launch...
19 January 2026 - Healthcare technology company Apiject Holdings Inc announced on Friday that it has signed a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina.The new facility is planned to house two advanc...
19 January 2026 - Clinical-stage biopharmaceutical company Atossa Therapeutics Inc (Nasdaq:ATOS) announced on Friday that it has received Orphan Drug Designation from the US Food and Drug Administration (FDA) Office of Orphan Products Development (OO...
16 January 2026 - US-based digital health company Profusa, Inc. (NASDAQ: PFSA), which develops tissue-integrated biosensors for continuous biochemical monitoring, announced on Friday the launch of a healthcare research version of its Lumee tissue oxy...